Monday, June 15, 2026

Apple Smashes Stock Price Record, Approaching $3.7 Trillion Market Cap

Apple reaches a record high market cap nearing $3.7 trillion, with shares rising to $243.01 in New York trading.

Samsung Bioepis Launches AI Academy: How 1,000 Employees Will Master AI by July 2026

Samsung Bioepis launches an AI training program for employees to enhance skills in biopharmaceuticals, boosting global competitiveness.

North Korea’s Hypersonic Missile Launch Show-Off…Focus on Unity Showing Off ‘Nuclear Deterrence’

North Korea conducted a hypersonic missile drill under Kim Jong Un, emphasizing military strength and achievements in rural development.

Tag: Yuflyma

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Celltrion’s Remsima SC: The Leading Autoimmune Drug with 68% Market Share in Europe

Celltrion's treatments for autoimmune diseases and cancer maintain strong market positions in Europe, bolstered by stable prescriptions and new products.

FDA Ruling Paves Way for Pharmacy Substitution of Yuflyma for Humira

Celltrion's Yuflyma receives FDA approval for interchangeability with Humira, boosting market confidence and distribution in the U.S.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.